Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.29ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.29ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.11.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.11.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.11.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.11.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.11.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.3.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.3.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.3.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.5.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.5.5.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.5.5.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.5.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.5.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.5.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used